Free Trial

Neogen (NEOG) Stock Price, News & Analysis

Neogen logo
$5.75 0.00 (0.00%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$5.84 +0.09 (+1.48%)
As of 08/29/2025 05:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Neogen Stock (NASDAQ:NEOG)

Key Stats

Today's Range
$5.74
$5.86
50-Day Range
$4.65
$5.75
52-Week Range
$3.87
$17.95
Volume
2.72 million shs
Average Volume
5.53 million shs
Market Capitalization
$1.25 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.50
Consensus Rating
Hold

Company Overview

Neogen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
72nd Percentile Overall Score

NEOG MarketRank™: 

Neogen scored higher than 72% of companies evaluated by MarketBeat, and ranked 282nd out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Neogen has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Neogen has only been the subject of 3 research reports in the past 90 days.

  • Read more about Neogen's stock forecast and price target.
  • Earnings Growth

    Earnings for Neogen are expected to grow by 28.95% in the coming year, from $0.38 to $0.49 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Neogen is -1.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Neogen is -1.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Neogen has a P/B Ratio of 0.60. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Neogen's valuation and earnings.
  • Percentage of Shares Shorted

    8.03% of the float of Neogen has been sold short.
  • Short Interest Ratio / Days to Cover

    Neogen has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Neogen has recently decreased by 5.84%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Neogen does not currently pay a dividend.

  • Dividend Growth

    Neogen does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.03% of the float of Neogen has been sold short.
  • Short Interest Ratio / Days to Cover

    Neogen has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Neogen has recently decreased by 5.84%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Neogen has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.05 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 39 news articles for Neogen this week, compared to 21 articles on an average week.
  • MarketBeat Follows

    4 people have added Neogen to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Neogen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.13% of the stock of Neogen is held by insiders.

  • Percentage Held by Institutions

    96.73% of the stock of Neogen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Neogen's insider trading history.
Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NEOG Stock News Headlines

Buffett to put 90% of his money in this one stock?
CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accounting firms like Deloitte and KPMG, Joel Litman (who’s also a member of the Global CFA Institute) figured out a unique, less-risky way to grow rich in the stock market. Litman says you don’t need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks, which have helped Litman’s own mom earn 3,400%.tc pixel
See More Headlines

NEOG Stock Analysis - Frequently Asked Questions

Neogen's stock was trading at $12.14 at the start of the year. Since then, NEOG shares have decreased by 52.6% and is now trading at $5.75.

Neogen Corporation (NASDAQ:NEOG) issued its earnings results on Wednesday, April, 9th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.12 by $0.02. The firm's revenue for the quarter was down 3.4% on a year-over-year basis.
Read the conference call transcript
.

Shares of Neogen split before market open on Tuesday, January 2nd 2018.The 4-3 split was announced on Friday, December 8th 2017. The newly issued shares were payable to shareholders after the market closes on Friday, December 29th 2017. An investor that had 100 shares of stock prior to the split would have 133 shares after the split.

Neogen's top institutional investors include Clarkston Capital Partners LLC (6.45%), William Blair Investment Management LLC (4.33%), Norges Bank (4.18%) and Mackenzie Financial Corp (3.60%). Insiders that own company stock include John Edward Adent, David H Naemura, James C Borel, Douglas Edward Jones, James P Tobin, Amy M Rocklin, Steven J Quinlan, Jason Warren Lilly, William T Boehm, Aashima Gupta and John Patrick Moylan.
View institutional ownership trends
.

Shares of NEOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neogen investors own include NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
4/09/2025
Today
8/30/2025
Next Earnings (Estimated)
10/09/2025
Fiscal Year End
5/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:NEOG
CIK
711377
Employees
2,110
Year Founded
1982

Price Target and Rating

High Price Target
$10.00
Low Price Target
$5.00
Potential Upside/Downside
+30.4%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($5.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
15.13
P/E Growth
N/A
Net Income
-$1.09 billion
Net Margins
-122.06%
Pretax Margin
-126.65%
Return on Equity
2.39%
Return on Assets
1.57%

Debt

Debt-to-Equity Ratio
0.42
Current Ratio
3.32
Quick Ratio
2.22

Sales & Book Value

Annual Sales
$894.66 million
Price / Sales
1.40
Cash Flow
$5.75 per share
Price / Cash Flow
1.00
Book Value
$9.54 per share
Price / Book
0.60

Miscellaneous

Outstanding Shares
217,210,000
Free Float
214,751,000
Market Cap
$1.25 billion
Optionable
Optionable
Beta
1.79

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:NEOG) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners